Preparing tooth-like structure using stem cell
09782443 · 2017-10-10
Assignee
Inventors
- Duanqing Pei (Guangzhou, CN)
- Jinglei Cai (Guangzhou, CN)
- Pengfei Liu (Guangzhou, CN)
- Shubin Chen (Guangzhou, CN)
- Yanmei Zhang (Guangzhou, CN)
Cpc classification
C12N2501/385
CHEMISTRY; METALLURGY
C12N2506/45
CHEMISTRY; METALLURGY
C12N2500/33
CHEMISTRY; METALLURGY
C12N2501/06
CHEMISTRY; METALLURGY
C07K14/51
CHEMISTRY; METALLURGY
A61K35/545
HUMAN NECESSITIES
A61P1/02
HUMAN NECESSITIES
C12N5/0654
CHEMISTRY; METALLURGY
International classification
A61K35/22
HUMAN NECESSITIES
C07K14/51
CHEMISTRY; METALLURGY
Abstract
The usage of a stem cell in preparation of a tooth-like structure is provided. And a culture medium, a method for preparing an epithelial-like cell, a kit for preparing an ameloblast, a method for preparing an ameloblast are also provided. Specifically, the culture medium comprises a basal medium, which is DMEM/F12 medium; N2 supplement; retinoic acid; and BMP-4.
Claims
1. A method of preparing a tooth-like structure, wherein said tooth-like structure is prepared from a human induced pluripotent stem cell, and wherein said human induced pluripotent stem cell is prepared from a stem cell derived from a urine cell.
2. The method of claim 1, wherein the tooth-like structure is produced in a mammalian animal by means of xenograft transplantation.
3. The method of claim 2, wherein the mammalian animal is at least one selected from a group consisting of mouse, rat, pig, dog, and monkey.
4. The method of claim 1, wherein the stem cell is induced to form an epithelial-like cell prior to the xenograft transplantation.
5. The method of claim 1, wherein the tooth-like structure comprises an ameloblast.
6. A method for preparing an ameloblast, comprising: preparing an epithelial-like cell by a method comprising culturing a stem cell using a first culture medium comprising a DMEM/F12 medium supplemented with about 1 wt. % N2 supplement, about 1 μM retinoic acid and about 25 ng/ml BMP-4, to induce the stem cell differentiating into the epithelial-like cell; preparing a dental mesenchyme from a first animal; recombining the epithelial-like cell with the dental mesenchyme to obtain a recombinant specimen; culturing the resulting recombinant specimen to obtain a reconstituted explant; and transplanting the reconstituted explant into a second animal for at a predetermined time to form the ameloblast, wherein the stem cell is an induced pluripotent stem cell derived from a urine cell.
7. The method of claim 6, wherein the stem cell is cultured for about 5-10 days.
8. The method of claim 6, wherein the first animal and the second animal are independently selected from a group consisting of mouse, rat, pig, dog, and monkey respectively.
9. The method of claim 7, wherein the first animal is a fetal mouse, and the second animal is a nude mouse.
10. The method of claim 9, wherein the dental mesenchyme is mechanically separated from a tooth germ, and the tooth germ is digested using a protease prior to the separation.
11. The method of claim 10, wherein the protease is a Dispase of about 0.75 mg/ml.
12. The method of claim 6, wherein the resulting recombinant specimen is cultured using a DMEM medium supplemented with FBS, non-essential amino acid, glutamine, penicillin and streptomycin.
13. The method of claim 9, wherein the recombinant tissue is transplanted into a space under a kidney capsule of the nude mouse.
14. The method of claim 6, wherein the predetermined time is about 2 to 4 weeks.
15. The method of claim 6, wherein the predetermined time is about 3 weeks.
16. The method of claim 6, wherein the stem cell is cultured using at least one medium selected from the group consisting of mTeSR1 medium, E8 medium, and KSR-conditioned medium prior to preparing the epithelial-like cell, wherein the medium is replaced with the first culture medium when the cultured stem cell reach a confluence of about 60-80%, to obtain the epithelial-like cell, said first culture medium being DMEM/F12 medium supplemented with a N2 supplement of about 1 wt. %, a retinoic acid of about 1 μM, and a BMP-4 of about 25 ng/ml.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) The aforementioned features and advantages of the invention as well as additional features and advantages thereof will be more clearly understood hereinafter as a result of a detailed description of preferred embodiments when taken in conjunction with the drawings, in which:
(2)
(3)
(4)
DETAILED DESCRIPTION OF THE EMBODIMENT
(5) The present disclosure will be described in detail with reference to the following examples. The standard laboratory practices of the inventors are illustrated in the following examples which are used to exemplify the mode of the present invention. The scope of the present invention shall not be construed as being limited to these examples. According to what is disclosed herein and the common level of those skilled in the art, it shall be appreciated that the following examples are only for illustration and may be subjected to various changes, modifications, and alterations without departing from the scope of the present invention. Unless otherwise stated, all the technologies concerned are conventional technologies in embryology, stem cell biology, molecular biology, tissue physiology immunology, histology, engineering, or other fields as well known by those skilled in the art.
(6) General Procedures
(7) Cell Culture:
(8) Human urine cells were cultured in primary medium contains DMEM/Ham's F12 1:1 (Hyclone), 10 wt. % of fetal bovine serum (FBS; PAA), SingleQuot Kit CC-4127 REGM (Lonza), ampothericin B and penicillin/streptomycin for 2 days and then changed to REBM (Renal Epithelial Basal 2 Medium, Lonza) medium containing SingleQuot Kit CC-4127 REGM (Lonza) (referred to as urine cell medium) during the following days. hESCs was purchased from NATIONAL STEM CELL BANK IN USA. iPSCs generated through retroviral vectors or oriP/EBNA episomal vectors (integration-free) were obtained from South Stem Cell Bank in China. Both hESCs and iPSCs were cultured on the Matrigel-coated plates in mTesR1 medium.
(9) Tooth Generation:
(10)
EXAMPLE 1
Production of Epithelial Sheets from hESCs and Integration-Free Human Urine Cell Derived iPSCs (ifhU-iPSCs)
(11) We first devised a way to obtain dental epithelia from hESCs or ifhU-iPSCs and decided on a stage-specific approach based on RA and BMP4 in N2 medium comprising a N2 supplement of about 1 wt. %, a retinoic acid of about 1 μM, and a BMP-4 of about 25 ng/ml. To this end, we obtained epithelial cells with keratinocyte-like morphology at D7 (
(12) In details,
(13) In the
(14) (b) shows qPCR of representative experiment showing the down regulation of ESC-specific transcription factor (Oct4) and up regulation of keratinized epithelial markers (K18, p63, K19, CD29, K14).
(15) (c) shows Western blotting for Oct4, p63, and K18 of lysates from H1 or ifhUl-iPSCs derived epithelial cells; GAPDH is the loading control.
(16) (d) shows Phase contrast captures and immunofluorescence staining [IF: p63 (red), K14 (green), DAPI (blue)] of epithelial sheets derived from H1 and ifhUl-iPSCs at D7 and D21. Scale bars correspond to 2000 and 200 μm, respectively.
(17) (e) shows Scanning electron microscope (SEM) and transmission electron microscopy (TEM) images of H1-ESCs and ifhU1-iPSCs derived epithelial sheets at D7 and D14. White arrowheads indicate desmosomes between epithelial cells of the sheet. Scale bars in SEM and TEM correspond to 20 and 0.5 μm respectively.
EXAMPLE 2
Generation of Tooth-Like Structure from Epithelial Sheets Derived from hESCs and ifhU-iPSCs
(18) We harvested D7 epithelial sheets and recombined them with the mouse dental mesenchyme in a mTeSR1™ medium, E8 medium, or KSR conditioned medium (wherein the medium comprises FBS of about 10 wt. %, glutamine of about 2 mM, non-essential amino acid of about 0.1 mM, penicillin of about 100 U/ml, and streptomycin of 100 U/ml), before transplantation into mouse subrenal capsule (
EXAMPLE 3
Characterization of Physical Properties of Tooth-Like Structures and Proportion of Tooth-Like Structure Generation
(19) We analyzed the hardness and elastic modulus of human adult teeth (human group), 3-week mouse teeth developed from tooth germs under kidney capsule (Mouse WT group), and the regenerative teeth from H1-ESCs and ifhU-iPSCs groups by Nano-indentation (
(20) In details,
(21) In the
(22) (b) shows Immunohistology and immunofluorescence staining in cross sections of the ifhU1-iPSCs derived tooth: top, HLA-I expression was specifically localized in the cytoplasm of human iPSC derived cells and tissues, including ameloblast layer (black arrowheads in b1 and b2) and epithelium-derived cyst (black arrows in b3); bottom, complementary expression of hNA (green) in the nucleus of the same regions in ameloblasts (white arrowheads) and cyst epithelial cells (white arrow). * indicated cyst. DAPI is shown in blue. Higher magnifications of hNA and DAPI in ameloblasts (white arrowheads) were shown in b4 and b5 respectively. Scale bars correspond to 200 μm.
(23) (c) shows Image of a piece of bone detected from E14.5 mouse dental mesenchyme being transplanted under kidney capsule for 3 weeks with positive BSP expression. Scale bars: 1000, 100, 100 μm orderly.
(24) (d) shows Nano-indentation analyses: Left: representative images of fractured enamel and dentin surfaces in adult human tooth group (human), group of 3-week mouse tooth from E14.5 tooth germs (Mouse-WT), regenerative tooth groups from H1-ESCs and ifhU-iPSCs; right: hardness and elastic modulus of enamel and dentin in above groups (each group: n=3).
(25) (e) shows Roman spectroscopy analyses of enamel and dentin from human, mouse, hESCs, and ifhU-iPSCs showed great similarity for all groups on Raman peaks, including 961 cm.sup.−1 (hydroxyapatite) in both enamel and dentin, and 1669 cm.sup.−1 (C═O stretching vibration), 2885 cm.sup.−1 and 2941 cm.sup.−1(C—H stretching vibration) in dentin.
(26) (f) shows efficiencies of tooth-like structures for H1 ESC line and 8 iPSC lines.
EXAMPLE 4
(27) In this example, human embryo stem cell (H1-ESC) and eight different lines of iPSC derived from urine cells are used to prepare ameloblast respectively in a way similar to the above examples. And the respective efficiency of obtaining ameloblast are compared among these stem cells, the results are shown in the following table I.
(28) TABLE-US-00001 TABLE I Number of newly formed Teeth/ Efficiency in term iPSC clone lines Number of recombinant specimen of percentage H1 -ESC 15/50 30% vUC1-iPSC-C1 6/42 14.3% UC1-iPSC-C1 12/50 24% UC5-iPSC-C1 13/56 23.2% UC5-iPSC-C2 15/59 25.4% UC5-iPSC-C3 6/40 15% UC7-iPSC-C3 12/52 23.1% UC7-iPSC-C6 7/60 11.7% UC7-iPSC-C9 17/59 28.8%
(29) In the above table, vUC1-iPSC-C1 represents a iPSC clone line obtained using a retroviral system, and the other 7 lines represent iPSC clone line obtained by means of Electroporation.
(30) As shown by the table I, both human embryo stem cell and iPSC can form a tooth-like structure containg ameloblast, and the efficiency of human embryo stem cell (H1-ESC) may reach 30%, which is higher than that of iPSC. All of the eight lines of iPSC above listed are derived from urine cell, which may have different efficiencies each other. Then we may draw a conclusion that both human embryo stem cell and iPSC can be used to prepare ameloblast with a relative higher efficiency.
(31) Although explanatory embodiments have been shown and described, it would be appreciated by those skilled in the art that changes, alternatives, and modifications all falling into the scope of the claims and their equivalents can be made in the embodiments without departing from spirit and principles of the disclosure.